The first China HLA Summit Forum and the 2019 China Blood Transfusion Association Human Tissue Antigen Professional Committee Annual Meeting, jointly organized by the China Bone Marrow Bank and Beijing Hospital, was successfully held in Fuzhou, Fujian Province from September 5th to 8th, 2019. More than 200 colleagues from both domestic and international sources participated in this summit forum.
At the opening ceremony, Lin Shengkui, Executive Vice President and Party Secretary of the Fujian Red Cross Society, delivered a speech on behalf of the Fujian Red Cross Society. Li Li, the director of the China Bone Marrow Bank, proposed the development goals of the National Bone Marrow Bank 2.0 version. Zhang Zhixin, Chairman of the Human Tissue Antigen Professional Committee of the China Blood Transfusion Association, proposed to promote in-depth research and widespread application of HLA, with the aim of improving the known HLA subtype platelet bank as the starting point, and initiating a major project of HLA selective transfusion
More than 20 new and old experts from various blood centers and hospitals active in the field of HLA research and application at home and abroad have conducted academic exchanges on new advances, new technologies, HLA and disease research, HLA and transplantation, HLA and blood transfusion, HLA evolution, HLA population genetics, HLA and other factors synergistic effects, HLA and bone marrow banks, platelet banks, HLA blood donor banks, second-generation sequencing, HLA antibody molecular monitoring and organ transplantation and hematopoietic stem cell transplantation.
Director Zhu, Deputy Director of the Zhejiang Provincial Blood Center, shared the discussion and analysis of ineffective platelet transfusion
Director Mao of the Blood Transfusion Research Institute of Chongqing Blood Center shared the article "Vigorously Promoting Precise Blood Transfusion and Opening up a New Era of Selective HLA Transfusion in China"
The meeting summarized the completion status of tasks for this year, with three tasks for 2019: summarizing the ineffectiveness of platelet transfusion, establishing a group standard system, and providing HLA technology training. 2: The main tasks for next year are three themes. Firstly, we will promote in-depth research and widespread application of HLA, and launch a major project of selective and comprehensive HLA transfusion with the aim of improving platelet banks. Director Mao's conference academic report reflects this theme. The improvement of the standard system for the second platelet bank and the increased promotion of the knowledge of ineffective platelet transfusion are also important tasks for next year, as reflected in Director Zhu's academic report. Thirdly, strengthen the construction of the committee.
Our company actively participated in this conference and shone brightly to ensure the smooth progress of the conference. In this meeting, the Henan Provincial Blood Center shared the usage of our company's HPA genotyping reagents and received unanimous recognition from the attendees present.
Henan Provincial Blood Center shares the usage of our company's products
The draft group standard for platelet bank construction was also announced at this meeting. Truly achieve standardized management and quality assurance of platelet gene banks.
Draft platelet group standard
Weihe's venue layout
This meeting truly provides policy support for the construction of platelet gene banks at the national level, and overall proposes three central tasks: group standards for building banks, promoting the integration of dual banks, and establishing alliance mechanisms. This conference has enabled domestic and foreign experts and scholars related to blood stations to further understand the necessity and regulatory standards of platelet gene bank construction, making the construction of the bank a consensus. Weihe will also accumulate and develop in the coming days, ensuring the widespread implementation of platelet bank building with better and more matching products, and assisting in the precise blood transfusion plan.
[Contact Information]
Address: 225300, East Side, 2nd Floor, Building G75, Phase 4, Yaocheng, Medical High tech Zone, Taizhou City, Jiangsu Province
Phone: 0523-86201335-8010 (product consultation)
Website: www.wehelpinc.com
Email: sales@wehelpinc.com